Adrienne G. Waks

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Adrienne G. Waks
May 28, 2025, 02:52 | Insight
Paolo Tarantino: Five review articles to read be ready for the practice changes in breast oncology expected from ASCO25
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Five review…
Feb 4, 2025, 15:30 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the Breast Cancer Research Digest - a…
Jan 31, 2025, 07:27 | Blog
Paolo Tarantino: Outcomes and Treatment Patterns for Stage I HER2-Positive Breast Cancer
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared on X: "Our latest study,…
Dec 10, 2024, 11:06 | Insight
Dana-Farber Researchers to Present at the 2024 San Antonio Breast Cancer Symposium
Researchers from Dana-Farber Cancer Institute will present over 30 studies at the 47th Annual San…
Nov 22, 2024, 17:22 | Insight
Chiara Corti: Estrogen Signaling in Early-Stage Breast Cancer
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “I am…
Sep 29, 2024, 15:48 | Blog
Elisabetta Bonzano: Dual HER2 inhibition, mechanisms of synergy
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "Dual HER2 inhibition:…
Sep 15, 2024, 08:33 | Drugs
Paolo Tarantino: Some HER2+ tumors melt upon dual anti-HER2 Treatment
Paolo Tarantino shared on X: "Some HER2+ tumors melt upon dual anti-HER2 Treatment; others require…
Jul 29, 2024, 11:19 | Insight
Rasha Aboelhassan: We can give TDM1 in stage I HER2 positive breast cancer
Rasha Aboelhassan shared a post on LinkedIn about a recent paper by Paolo Tarantino et al., commenting:…
Jul 20, 2024, 11:01 | Insight
Paolo Tarantino: Thanks to ESMO for featuring our 5-year analysis of the ATEMPT randomized phase 3 trial
Paolo Tarantino shared a post on LinkedIn about a paper titled "Adjuvant Trastuzumab Emtansine Versus…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
All: 10 Posts: 1 - 100
Special Coverage